Company Filing History:
Years Active: 2011
Title: Innovator Andrzej Jan Brzozowski: Pioneering Fast Dispersing Dosage Forms
Introduction
Andrzej Jan Brzozowski is a notable inventor based in Swindon, GB, recognized for his innovative contributions in the pharmaceutical industry. He holds a significant patent that addresses the formulation of fast dispersing dosage forms utilizing fish gelatin, showcasing his commitment to enhancing pharmaceutical compositions for improved efficacy.
Latest Patents
Brzozowski's patent, titled "Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight," details a sophisticated method for creating pharmaceutical compositions. The invention involves using fish gelatin as a carrier, where the selection is based on the molecular weight profile. This innovative approach allows for tailored formulations, optimizing performance based on varying concentrations of gelatins, ultimately benefitting the end-user with more effective medication delivery options.
Career Highlights
At R.P. Scherer Technologies, Inc., Brzozowski has dedicated his career to exploring advanced pharmaceutical solutions. His expertise in gelatin-based formulations contributes significantly to the development of effective health products. The implementation of his patent reflects his ability to bridge science and practical application in pharmaceuticals.
Collaborations
During his career, Andrzej has collaborated with esteemed colleagues such as Desmond Yik Teng Wong and Leon Grother. Together, they have worked towards innovating new techniques and formulations to enhance drug delivery systems. Their combined efforts not only strengthen their company's portfolio but also contribute to advancements within the pharmaceutical sector.
Conclusion
Andrzej Jan Brzozowski exemplifies the spirit of innovation in the pharmaceutical domain. His patent for fast dispersing dosage forms utilizing fish gelatin marks a significant milestone in enhancing drug formulation methods. With a promising career at R.P. Scherer Technologies, Inc., and collaborative efforts with talented colleagues, Brzozowski continues to pave the way for future advancements in pharmaceutical sciences.